Simplifying Global Compliance
U.S. FDA May Miss MDUFMA Deadline, Industry Sees Progress
International Medical Device Regulatory Monitor
The U.S. device industry and the U.S. Food and Drug Administration (FDA) are closer to an agreement on reauthorizing the Medical Device User Fee and Modernization Act (MDUFMA), but chances are slim that the agency will meet a Jan. 15 goal to deliver that agreement to Congress.
To View This Article:
Subscribe To International Medical Device Regulatory Monitor
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing